The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Hearing Research
- Vol. 278 (1-2) , 69-76
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effects of Localized Neurotrophin Gene Expression on Spiral Ganglion Neuron Resprouting in the Deafened CochleaMolecular Therapy, 2010
- Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleaeExperimental Neurology, 2010
- Enhanced Survival of Spiral Ganglion Cells After Cessation of Treatment with Brain-Derived Neurotrophic Factor in Deafened Guinea PigsJournal of the Association for Research in Otolaryngology, 2009
- Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neuronsHearing Research, 2008
- Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing lossHearing Research, 2008
- Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3Journal of Comparative Neurology, 2005
- CAR: A virus receptor within the tight junctionAdvanced Drug Delivery Reviews, 2005
- Chronic depolarization enhances the trophic effects of brain‐derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing lossJournal of Comparative Neurology, 2005
- In Vitro and In Vivo Assessment of the Ability of Adeno‐Associated Virus–Brain‐Derived Neurotrophic Factor to Enhance Spiral Ganglion Cell Survival Following Ototoxic InsultThe Laryngoscope, 2002
- Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virusGene Therapy, 1998